Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Tomas Rejtar"'
Autor:
Hasmik Keshishian, E Robert McDonald, Filip Mundt, Randy Melanson, Karsten Krug, Dale A Porter, Luke Wallace, Dominique Forestier, Bokang Rabasha, Sara E Marlow, Judit Jane‐Valbuena, Ellen Todres, Harrison Specht, Margaret Lea Robinson, Pierre M Jean Beltran, Ozgun Babur, Meagan E Olive, Javad Golji, Eric Kuhn, Michael Burgess, Melanie A MacMullan, Tomas Rejtar, Karen Wang, DR Mani, Shankha Satpathy, Michael A Gillette, William R Sellers, Steven A Carr
Publikováno v:
Molecular Systems Biology, Vol 17, Iss 9, Pp 1-22 (2021)
Abstract Reliable methods to quantify dynamic signaling changes across diverse pathways are needed to better understand the effects of disease and drug treatment in cells and tissues but are presently lacking. Here, we present SigPath, a targeted mas
Externí odkaz:
https://doaj.org/article/8c21ac714ff142d89c9c58dde8847a35
Autor:
Maura A Crowley, Donita L Garland, Holger Sellner, Angela Banks, Lin Fan, Tomas Rejtar, Natasha Buchanan, Omar Delgado, Yong Yao Xu, Sandra Jose, Christopher M Adams, Muneto Mogi, Karen Wang, Chad E Bigelow, Stephen Poor, Karen Anderson, Bruce D Jaffee, Ganesh Prasanna, Cynthia Grosskreutz, Rosario Fernandez-Godino, Eric A Pierce, Thaddeus P Dryja, Sha-Mei Liao
Publikováno v:
Human Molecular Genetics. 32:204-217
EFEMP1 R345W is a dominant mutation causing Doyne honeycomb retinal dystrophy/malattia leventinese (DHRD/ML), a rare blinding disease with clinical pathology similar to age-related macular degeneration (AMD). Aged Efemp1 R345W/R345W knock-in mice (Ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fec58b40ea8387ba6f2edc6bd8b972d3
https://doi.org/10.1093/hmg/ddac187
https://doi.org/10.1093/hmg/ddac187
Autor:
Joseph A. D'Alessio, Glenn Dranoff, Joel P. Wagner, Kimberly Aardalen, Tiancen Hu, David A. Ruddy, Tomas Rejtar, William R. Tschantz, Katherine Seiss, Katie Russo, Markus Vogel, Sabine Deutsch, Srinivas Chakravarthy, Rajiv Chopra, Brian Granda, Casey Landry, Alyssa Grantham, Si-Qi Liu
Table S5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e2ba7e7600f301da5f36ec6412b1e2a
https://doi.org/10.1158/2326-6066.22543066.v1
https://doi.org/10.1158/2326-6066.22543066.v1
Autor:
Joseph A. D'Alessio, Glenn Dranoff, Joel P. Wagner, Kimberly Aardalen, Tiancen Hu, David A. Ruddy, Tomas Rejtar, William R. Tschantz, Katherine Seiss, Katie Russo, Markus Vogel, Sabine Deutsch, Srinivas Chakravarthy, Rajiv Chopra, Brian Granda, Casey Landry, Alyssa Grantham, Si-Qi Liu
Supplementary Figures and Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87871a76cbc3aa1c923ef792d0181235
https://doi.org/10.1158/2326-6066.22543081.v1
https://doi.org/10.1158/2326-6066.22543081.v1
Autor:
Joseph A. D'Alessio, Glenn Dranoff, Joel P. Wagner, Kimberly Aardalen, Tiancen Hu, David A. Ruddy, Tomas Rejtar, William R. Tschantz, Katherine Seiss, Katie Russo, Markus Vogel, Sabine Deutsch, Srinivas Chakravarthy, Rajiv Chopra, Brian Granda, Casey Landry, Alyssa Grantham, Si-Qi Liu
CD3-bispecific antibodies represent an important therapeutic strategy in oncology. These molecules work by redirecting cytotoxic T cells to antigen-bearing tumor cells. Although CD3-bispecific antibodies have been developed for several clinical indic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c773deaaa2e2b6fd296bf63ecf07463f
https://doi.org/10.1158/2326-6066.c.6550126.v1
https://doi.org/10.1158/2326-6066.c.6550126.v1
Autor:
Tomas Rejtar, Markus Vogel, Srinivas Chakravarthy, Joseph Anthony D'alessio, Katie Russo, Alyssa Grantham, David A. Ruddy, Sabine Deutsch, Si-Qi Liu, Katherine Seiss, Tiancen Hu, William R. Tschantz, Glenn Dranoff, Casey Landry, Rajiv Chopra, Joel Wagner, Brian Granda, Kimberly Aardalen
Publikováno v:
Cancer Immunol Res
CD3-bispecific antibodies represent an important therapeutic strategy in oncology. These molecules work by redirecting cytotoxic T cells to antigen-bearing tumor cells. Although CD3-bispecific antibodies have been developed for several clinical indic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a176a8f79f4e3fa601fbb0ac0b7fd736
https://doi.org/10.1158/2326-6066.cir-20-0080
https://doi.org/10.1158/2326-6066.cir-20-0080
Autor:
Michael Burgess, Özgün Babur, Tomas Rejtar, Meagan E. Olive, E. Robert McDonald, Dominique Forestier, Filip Mundt, Michael A. Gillette, Dale Porter, Pierre M. Jean Beltran, Steven A. Carr, Ellen Todres, Luke Wallace, Karen Wang, Javad Golji, Karsten Krug, Mani, Melanie A. MacMullan, Sara E Marlow, Randy Melanson, Judit Jané-Valbuena, Margaret Lea Robinson, Eric Kuhn, William R. Sellers, Harrison Specht, Hasmik Keshishian, Shankha Satpathy, Bokang Rabasha
Publikováno v:
Molecular Systems Biology
Molecular Systems Biology, Vol 17, Iss 9, Pp n/a-n/a (2021)
Molecular Systems Biology, Vol 17, Iss 9, Pp n/a-n/a (2021)
Reliable methods to quantify dynamic signaling changes across diverse pathways are needed to better understand the effects of disease and drug treatment in cells and tissues but are presently lacking. Here, we present SigPath, a targeted mass spectro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::248a364c882d8ccbcf629e77f5977905
http://europepmc.org/articles/PMC8474009
http://europepmc.org/articles/PMC8474009
Autor:
Laura A Laviolette, Jonas Wilson, Julia Koller, Christopher Neil, Peter Hulick, Tomas Rejtar, Barry Karger, Bin Tean Teh, Othon Iliopoulos
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e66775 (2013)
The Birt-Hogg-Dube disease occurs as a result of germline mutations in the human Folliculin gene (FLCN), and is characterized by clinical features including fibrofolliculomas, lung cysts and multifocal renal neoplasia. Clinical and genetic evidence s
Externí odkaz:
https://doaj.org/article/9f02924d045942aa865210ebfded7ed8
Autor:
D. Forestier, Levi A. Garraway, S. E. Marlow, Michael A. Gillette, Tomas Rejtar, Dale Porter, William R. Sellers, D. R. Mani, F. Mundth, Luke Wallace, Shankha Satpathy, Keshi Wang, Harrison Specht, Judit Jané-Valbuena, Earl Mcdonald, Bokang Rabasha, Randy Melanson, Karsten Krug, Eric Kuhn, Karl R. Clauser, Michael Burgess, Javad Golji, Hasmik Keshishian, Steven A. Carr, Melanie A. MacMullan, Ellen Todres
Reliable methods to quantify dynamic signaling changes across diverse pathways are needed to better understand the effects of disease and drug-treatment in cells and tissues but are presently lacking. Here we present SigPath, a targeted mass spectrom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a15728a4ae35bee30ef6a6bbf1c7615
https://doi.org/10.1101/2020.12.08.415281
https://doi.org/10.1101/2020.12.08.415281
Autor:
Mark P. Jedrychowski, Javad Golji, Devin K. Schweppe, Ellen Gelfand, Christopher M. Rose, Tomas Rejtar, Levi A. Garraway, Steven P. Gygi, Gregory V. Kryukov, Marian Kalocsay, Brian K. Erickson, Y. Karen Wang, E. Robert McDonald, Frank Stegmeier, Mahmoud Ghandi, Judit Jané-Valbuena, William R. Sellers, Dale Porter, John Szpyt, David P. Nusinow
Publikováno v:
Cell
Proteins are essential agents of biological processes. To date, large-scale profiling of cell line collections including the Cancer Cell Line Encyclopedia (CCLE) has focused primarily on genetic information whereas deep interrogation of the proteome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8863298629a805432e399af03a87038e
https://pubmed.ncbi.nlm.nih.gov/31978347
https://pubmed.ncbi.nlm.nih.gov/31978347